Form 4: Integra LifeSciences EVP Reports Stock Transactions

Integra LifeSciences EVP Robert T. Davis Jr. reported the acquisition of 43,350 restricted stock units and the disposal of 9,174 common shares for tax purposes.

Summary

• Robert T. Davis Jr., EVP & President, TT at Integra LifeSciences Holdings Corp (IART), reported transactions involving the company's common stock and restricted stock units (RSUs).
• On March 10, 2026, 687 shares of common stock were disposed of at a price of $9.55 per share, leaving 74,874 shares beneficially owned.
• On March 11, 2026, an additional 8,487 shares of common stock were disposed of at a price of $9.61 per share, resulting in 66,387 shares beneficially owned.
• These disposals, totaling 9,174 shares, were marked with transaction code 'F', indicating shares withheld to cover tax obligations upon the vesting of equity awards.
• On March 11, 2026, Mr. Davis acquired 43,350 Restricted Stock Units (RSUs) at a price of $0, representing a grant.
• These RSUs will vest over three years: 33% on the first anniversary, 33% on the second anniversary, and 34% on the third anniversary of the grant date (March 11, 2026).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-slightly positive event. The RSU grant aligns executive interests with shareholders, while the share disposals are routine for tax purposes and do not indicate a change in sentiment.

Positives

• The grant of 43,350 Restricted Stock Units (RSUs) aligns executive interests with the long-term performance and shareholder value of Integra LifeSciences.

Negatives

• The disposal of 9,174 common shares, while for tax purposes, reduces the direct common stock ownership of the executive.

Future Outlook

The Restricted Stock Units granted to Robert T. Davis Jr. are scheduled to vest in three annual installments, with 33% vesting on the first and second anniversaries and 34% on the third anniversary of the March 11, 2026 grant date.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units and subsequent tax-related share disposals are standard practices in executive compensation across various industries, designed to incentivize long-term performance and manage tax liabilities associated with equity awards.

Stakeholder Impact

• Shareholders are impacted by the change in executive ownership, with the grant of Restricted Stock Units aligning executive interests with long-term company performance.

Next Steps

• Vesting of Restricted Stock Units on the first, second, and third anniversaries of the March 11, 2026 grant date.

Key Dates

Keywords

Integra LifeSciences, IART, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, Equity Award, Stock Disposal